Affectis Pharmaceuticals' Series D Round

Affectis Pharmaceuticals raised a round of funding on March 22, 2010.

Affectis Pharmaceuticals, fka neuronova, is a biopharmaceutical company developing drugs for the treatment of psychiatric and inflammatory disorders.…

Articles about Affectis Pharmaceuticals' Series D Round: